These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30610617)

  • 1. Post-translational modification of the death receptor complex as a potential therapeutic target in cancer.
    Kang K; Lee SR; Piao X; Hur GM
    Arch Pharm Res; 2019 Jan; 42(1):76-87. PubMed ID: 30610617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.
    Sessler T; Healy S; Samali A; Szegezdi E
    Pharmacol Ther; 2013 Nov; 140(2):186-99. PubMed ID: 23845861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational modifications as key regulators of TNF-induced necroptosis.
    Liu X; Shi F; Li Y; Yu X; Peng S; Li W; Luo X; Cao Y
    Cell Death Dis; 2016 Jul; 7(7):e2293. PubMed ID: 27383048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sweet modification and regulation of death receptor signalling pathway.
    Moriwaki K; Chan FKM; Miyoshi E
    J Biochem; 2021 Sep; 169(6):643-652. PubMed ID: 33752241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of life-or-death decisions by RIP1 kinase.
    Christofferson DE; Li Y; Yuan J
    Annu Rev Physiol; 2014; 76():129-50. PubMed ID: 24079414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Ubiquitination in Apoptosis and Necroptosis.
    Roberts JZ; Crawford N; Longley DB
    Cell Death Differ; 2022 Feb; 29(2):272-284. PubMed ID: 34912054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as regulators of death receptors signaling.
    Garofalo M; Condorelli GL; Croce CM; Condorelli G
    Cell Death Differ; 2010 Feb; 17(2):200-8. PubMed ID: 19644509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the ripoptosome and its components: implications for anti-inflammatory and cancer therapy.
    Schilling R; Geserick P; Leverkus M
    Methods Enzymol; 2014; 545():83-102. PubMed ID: 25065887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'complexities' of life and death: death receptor signalling platforms.
    Dickens LS; Powley IR; Hughes MA; MacFarlane M
    Exp Cell Res; 2012 Jul; 318(11):1269-77. PubMed ID: 22542855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.
    Borghi A; Verstrepen L; Beyaert R
    Biochem Pharmacol; 2016 Sep; 116():1-10. PubMed ID: 26993379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of death receptors--relevance in cancer therapies.
    de Thonel A; Eriksson JE
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):123-32. PubMed ID: 16126242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of death receptor signaling by the ubiquitin system.
    Wertz IE; Dixit VM
    Cell Death Differ; 2010 Jan; 17(1):14-24. PubMed ID: 19893571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies of death receptors.
    Driscoll PC
    Methods Enzymol; 2014; 545():201-42. PubMed ID: 25065892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies?
    Keresztes A; Streicher JM
    FEBS Lett; 2017 Oct; 591(20):3235-3251. PubMed ID: 28948607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Cell Biology of Apoptosis and Necroptosis in Cancer.
    Dillon CP; Green DR
    Adv Exp Med Biol; 2016; 930():1-23. PubMed ID: 27558815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational control of NF-κB signaling by ubiquitination.
    Won M; Byun HS; Park KA; Hur GM
    Arch Pharm Res; 2016 Aug; 39(8):1075-84. PubMed ID: 27287455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis.
    Thompson LL; Guppy BJ; Sawchuk L; Davie JR; McManus KJ
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):363-76. PubMed ID: 23609752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
    Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
    Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological implication of protein post-translational modifications in cancer.
    Pan S; Chen R
    Mol Aspects Med; 2022 Aug; 86():101097. PubMed ID: 35400524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting p38 MAP kinase signaling in cancer through post-translational modifications.
    Zou X; Blank M
    Cancer Lett; 2017 Jan; 384():19-26. PubMed ID: 27725227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.